Skip to main content
Top
Published in: Acta Neurochirurgica 3/2011

Open Access 01-03-2011 | Review Article

Gene expression profiling of meningiomas: current status after a decade of microarray-based transcriptomic studies

Authors: Mads Aarhus, Morten Lund-Johansen, Per Morten Knappskog

Published in: Acta Neurochirurgica | Issue 3/2011

Login to get access

Abstract

Purpose

This article provides a review of the transcriptomic expression profiling studies that have been performed on meningiomas so far. We discuss some future prospects and challenges ahead in the field of gene expression profiling.

Methods

We performed a systematic search in the PubMed and EMBASE databases in May 2010 using the following search terms alone or in combination: “meningioma”, “microarray analysis”, “oligonucleotide array sequence analysis”, or “gene expression profiling”. Only original research articles in English that had used RNA hybridized to high-resolution microarray chips to generate gene expression profiles were included.

Results

We identified 13 articles matching the inclusion criteria. All studies had been performed during the last decade.

Conclusions

The main results of the studies can be grouped in three categories: (1) several groups have identified meningioma-specific genes and genes associated with the three WHO grades, and the main histological subtypes of grade I meningiomas; (2) one publication has shown that the general transcription profile of samples of all WHO grades differs in vivo and in vitro; (3) one report provides evidence that microarray technology can be used in an automated fashion to classify tumors. Due to lack of consensus on how microarray data are presented, possible general trends found across the studies are difficult to extract. This could obstruct the discovery of important genes and pathways universally involved in meningioma biology.
Literature
1.
go back to reference Ramaswamy S (2004) Translating cancer genomics into clinical oncology. N Engl J Med 350:1814–1816CrossRefPubMed Ramaswamy S (2004) Translating cancer genomics into clinical oncology. N Engl J Med 350:1814–1816CrossRefPubMed
2.
go back to reference Mischel PS, Cloughesy TF, Nelson SF (2004) DNA-microarray analysis of brain cancer: molecular classification for therapy. Nat Rev Neurosci 5:782–792CrossRefPubMed Mischel PS, Cloughesy TF, Nelson SF (2004) DNA-microarray analysis of brain cancer: molecular classification for therapy. Nat Rev Neurosci 5:782–792CrossRefPubMed
3.
go back to reference Stekel D (2003) Microarray bioinformatics. Cambridge University Press, CambridgeCrossRef Stekel D (2003) Microarray bioinformatics. Cambridge University Press, CambridgeCrossRef
4.
go back to reference OH LDN, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system. World Health Organization IARC, Lyon OH LDN, Wiestler OD, Cavenee WK (2007) WHO classification of tumours of the central nervous system. World Health Organization IARC, Lyon
5.
go back to reference Arai E, Ikeuchi T, Karasawa S, Tamura A, Yamamoto K, Kida M, Ichimura K, Yuasa Y, Tonomura A (1992) Constitutional translocation t(4, 22) (q12;q12.2) associated with neurofibromatosis type 2. Am J Med Genet 44:163–167CrossRefPubMed Arai E, Ikeuchi T, Karasawa S, Tamura A, Yamamoto K, Kida M, Ichimura K, Yuasa Y, Tonomura A (1992) Constitutional translocation t(4, 22) (q12;q12.2) associated with neurofibromatosis type 2. Am J Med Genet 44:163–167CrossRefPubMed
6.
go back to reference Rouleau GA, Seizinger BR, Wertelecki W, Haines JL, Superneau DW, Martuza RL, Gusella JF (1990) Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. Am J Hum Genet 46:323–328PubMed Rouleau GA, Seizinger BR, Wertelecki W, Haines JL, Superneau DW, Martuza RL, Gusella JF (1990) Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. Am J Hum Genet 46:323–328PubMed
7.
go back to reference Wertelecki W, Rouleau GA, Superneau DW, Forehand LW, Williams JP, Haines JL, Gusella JF (1988) Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. N Engl J Med 319:278–283CrossRefPubMed Wertelecki W, Rouleau GA, Superneau DW, Forehand LW, Williams JP, Haines JL, Gusella JF (1988) Neurofibromatosis 2: clinical and DNA linkage studies of a large kindred. N Engl J Med 319:278–283CrossRefPubMed
8.
go back to reference Wolff RK, Frazer KA, Jackler RK, Lanser MJ, Pitts LH, Cox DR (1992) Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. Am J Hum Genet 51:478–485PubMed Wolff RK, Frazer KA, Jackler RK, Lanser MJ, Pitts LH, Cox DR (1992) Analysis of chromosome 22 deletions in neurofibromatosis type 2-related tumors. Am J Hum Genet 51:478–485PubMed
9.
go back to reference Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey JA (1994) Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosom Cancer 9:296–298CrossRefPubMed Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey JA (1994) Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosom Cancer 9:296–298CrossRefPubMed
10.
go back to reference Ikeda K, Saeki Y, Gonzalez-Agosti C, Ramesh V, Chiocca EA (1999) Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer. J Neurosurg 91:85–92CrossRefPubMed Ikeda K, Saeki Y, Gonzalez-Agosti C, Ramesh V, Chiocca EA (1999) Inhibition of NF2-negative and NF2-positive primary human meningioma cell proliferation by overexpression of merlin due to vector-mediated gene transfer. J Neurosurg 91:85–92CrossRefPubMed
11.
go back to reference Peyrard M, Pan HQ, Kedra D, Fransson I, Swahn S, Hartman K, Clifton SW, Roe BA, Dumanski JP (1996) Structure of the promoter and genomic organization of the human beta’-adaptin gene (BAM22) from chromosome 22q12. Genomics 36:112–117CrossRefPubMed Peyrard M, Pan HQ, Kedra D, Fransson I, Swahn S, Hartman K, Clifton SW, Roe BA, Dumanski JP (1996) Structure of the promoter and genomic organization of the human beta’-adaptin gene (BAM22) from chromosome 22q12. Genomics 36:112–117CrossRefPubMed
12.
go back to reference Zucman-Rossi J, Legoix P, Thomas G (1996) Identification of new members of the Gas2 and Ras families in the 22q12 chromosome region. Genomics 38:247–254CrossRefPubMed Zucman-Rossi J, Legoix P, Thomas G (1996) Identification of new members of the Gas2 and Ras families in the 22q12 chromosome region. Genomics 38:247–254CrossRefPubMed
13.
go back to reference Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823CrossRefPubMed Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820–823CrossRefPubMed
14.
go back to reference Watson MA, Gutmann DH, Peterson K, Chicoine MR, Kleinschmidt-DeMasters BK, Brown HG, Perry A (2002) Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol 161:665–672CrossRefPubMed Watson MA, Gutmann DH, Peterson K, Chicoine MR, Kleinschmidt-DeMasters BK, Brown HG, Perry A (2002) Molecular characterization of human meningiomas by gene expression profiling using high-density oligonucleotide microarrays. Am J Pathol 161:665–672CrossRefPubMed
15.
go back to reference Sasaki T, Hankins GR, Helm GA (2003) Comparison of gene expression profiles between frozen original meningiomas and primary cultures of the meningiomas by GeneChip. Neurosurgery 52:892–898, discussion 898–899CrossRefPubMed Sasaki T, Hankins GR, Helm GA (2003) Comparison of gene expression profiles between frozen original meningiomas and primary cultures of the meningiomas by GeneChip. Neurosurgery 52:892–898, discussion 898–899CrossRefPubMed
16.
go back to reference Fathallah-Shaykh HM, He B, Zhao LJ, Engelhard HH, Cerullo L, Lichtor T, Byrne R, Munoz L, Von Roenn K, Rosseau GL, Glick R, Sherman C, Farooq K (2003) Genomic expression discovery predicts pathways and opposing functions behind phenotypes. J Biol Chem 278:23830–23833CrossRefPubMed Fathallah-Shaykh HM, He B, Zhao LJ, Engelhard HH, Cerullo L, Lichtor T, Byrne R, Munoz L, Von Roenn K, Rosseau GL, Glick R, Sherman C, Farooq K (2003) Genomic expression discovery predicts pathways and opposing functions behind phenotypes. J Biol Chem 278:23830–23833CrossRefPubMed
17.
go back to reference Wrobel G, Roerig P, Kokocinski F, Neben K, Hahn M, Reifenberger G, Lichter P (2005) Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int J Cancer 114:249–256CrossRefPubMed Wrobel G, Roerig P, Kokocinski F, Neben K, Hahn M, Reifenberger G, Lichter P (2005) Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression. Int J Cancer 114:249–256CrossRefPubMed
18.
go back to reference Lusis EA, Watson MA, Chicoine MR, Lyman M, Roerig P, Reifenberger G, Gutmann DH, Perry A (2005) Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 65:7121–7126CrossRefPubMed Lusis EA, Watson MA, Chicoine MR, Lyman M, Roerig P, Reifenberger G, Gutmann DH, Perry A (2005) Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma. Cancer Res 65:7121–7126CrossRefPubMed
19.
go back to reference Sayagues JM, Tabernero MD, Maillo A, Trelles O, Espinosa AB, Sarasquete ME, Merino M, Rasillo A, Vera JF, Santos-Briz A, de AE G-M, MC OA (2006) Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression. J Neuropathol Exp Neurol 65:445–454CrossRefPubMed Sayagues JM, Tabernero MD, Maillo A, Trelles O, Espinosa AB, Sarasquete ME, Merino M, Rasillo A, Vera JF, Santos-Briz A, de AE G-M, MC OA (2006) Microarray-based analysis of spinal versus intracranial meningiomas: different clinical, biological, and genetic characteristics associated with distinct patterns of gene expression. J Neuropathol Exp Neurol 65:445–454CrossRefPubMed
20.
go back to reference Carvalho LH, Smirnov I, Baia GS, Modrusan Z, Smith JS, Jun P, Costello JF, McDermott MW, Vandenberg SR, Lal A (2007) Molecular signatures define two main classes of meningiomas. Mol Cancer 6:64CrossRefPubMed Carvalho LH, Smirnov I, Baia GS, Modrusan Z, Smith JS, Jun P, Costello JF, McDermott MW, Vandenberg SR, Lal A (2007) Molecular signatures define two main classes of meningiomas. Mol Cancer 6:64CrossRefPubMed
21.
go back to reference Aarhus M, Bruland O, Bredholt G, Lybaek H, Husebye ES, Krossnes BK, Vedeler C, Wester K, Lund-Johansen M, Knappskog PM (2008) Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas. J Neurooncol 88(3):251–259CrossRefPubMed Aarhus M, Bruland O, Bredholt G, Lybaek H, Husebye ES, Krossnes BK, Vedeler C, Wester K, Lund-Johansen M, Knappskog PM (2008) Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas. J Neurooncol 88(3):251–259CrossRefPubMed
22.
go back to reference Lillehei KO, Donson AM, Kleinschmidt-DeMasters BK (2008) Radiation-induced meningiomas: clinical, cytogenetic, and microarray features. Acta Neuropathol 116:289–301CrossRefPubMed Lillehei KO, Donson AM, Kleinschmidt-DeMasters BK (2008) Radiation-induced meningiomas: clinical, cytogenetic, and microarray features. Acta Neuropathol 116:289–301CrossRefPubMed
23.
go back to reference Hankins GR, Sasaki T, Lieu AS, Saulle D, Karimi K, Li JZ, Helm GA (2008) Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor. Neurosurgery 63:771–780, discussion 780–771CrossRefPubMed Hankins GR, Sasaki T, Lieu AS, Saulle D, Karimi K, Li JZ, Helm GA (2008) Identification of the deleted in liver cancer 1 gene, DLC1, as a candidate meningioma tumor suppressor. Neurosurgery 63:771–780, discussion 780–771CrossRefPubMed
24.
go back to reference Claus EB, Park PJ, Carroll R, Chan J, Black PM (2008) Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res 68:314–322CrossRefPubMed Claus EB, Park PJ, Carroll R, Chan J, Black PM (2008) Specific genes expressed in association with progesterone receptors in meningioma. Cancer Res 68:314–322CrossRefPubMed
25.
go back to reference Fevre-Montange M, Champier J, Durand A, Wierinckx A, Honnorat J, Guyotat J, Jouvet A (2009) Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. Int J Oncol 35:1395–1407CrossRefPubMed Fevre-Montange M, Champier J, Durand A, Wierinckx A, Honnorat J, Guyotat J, Jouvet A (2009) Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype. Int J Oncol 35:1395–1407CrossRefPubMed
26.
go back to reference Castells X, Garcia-Gomez JM, Navarro A, Acebes JJ, Godino O, Boluda S, Barcelo A, Robles M, Arino J, Arus C (2009) Automated brain tumor biopsy prediction using single-labeling cDNA microarrays-based gene expression profiling. Diagn Mol Pathol 18:206–218CrossRefPubMed Castells X, Garcia-Gomez JM, Navarro A, Acebes JJ, Godino O, Boluda S, Barcelo A, Robles M, Arino J, Arus C (2009) Automated brain tumor biopsy prediction using single-labeling cDNA microarrays-based gene expression profiling. Diagn Mol Pathol 18:206–218CrossRefPubMed
27.
go back to reference Shi L, Tong W, Fang H, Scherf U, Han J, Puri RK, Frueh FW, Goodsaid FM, Guo L, Su Z, Han T, Fuscoe JC, Xu ZA, Patterson TA, Hong H, Xie Q, Perkins RG, Chen JJ, Casciano DA (2005) Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinform 6(Suppl 2):S12CrossRef Shi L, Tong W, Fang H, Scherf U, Han J, Puri RK, Frueh FW, Goodsaid FM, Guo L, Su Z, Han T, Fuscoe JC, Xu ZA, Patterson TA, Hong H, Xie Q, Perkins RG, Chen JJ, Casciano DA (2005) Cross-platform comparability of microarray technology: intra-platform consistency and appropriate data analysis procedures are essential. BMC Bioinform 6(Suppl 2):S12CrossRef
28.
go back to reference Sotiriou C, Piccart MJ (2007) Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer 7:545–553CrossRefPubMed Sotiriou C, Piccart MJ (2007) Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer 7:545–553CrossRefPubMed
29.
go back to reference Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008). Nature 455(7216):1061–1068 Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008). Nature 455(7216):1061–1068
Metadata
Title
Gene expression profiling of meningiomas: current status after a decade of microarray-based transcriptomic studies
Authors
Mads Aarhus
Morten Lund-Johansen
Per Morten Knappskog
Publication date
01-03-2011
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 3/2011
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-010-0906-0

Other articles of this Issue 3/2011

Acta Neurochirurgica 3/2011 Go to the issue